UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Immune Cell Composition in Human Non-small Cell Lung Cancer

Frontiers in immunology, 2019-02, Vol.9, p.3101

2019

Volltextzugriff (PDF)

The immune microenvironment in non‐small cell lung cancer is predictive of prognosis after surgery

Molecular oncology, 2019-05, Vol.13 (5), p.1166-1179

2019

Volltextzugriff (PDF)

Osimertinib in T790M-positive and -negative patients with EGFR-mutated advanced non-small cell lung cancer (the TREM-study)

Lung cancer (Amsterdam, Netherlands), 2020-05, Vol.143, p.27-35

2020

Volltextzugriff (PDF)

A multi‐omic study reveals BTG2 as a reliable prognostic marker for early‐stage non‐small cell lung cancer

Molecular oncology, 2018-06, Vol.12 (6), p.913-924

2018

Volltextzugriff (PDF)

Patient-reported health-related quality of life from a randomized phase II trial comparing standard-dose with high-dose twice daily thoracic radiotherapy in limited stage small-cell lung cancer

Lung cancer (Amsterdam, Netherlands), 2022-04, Vol.166, p.49-57

2022

Volltextzugriff (PDF)

Evaluation of sex inequity in lung-cancer-specific survival

Acta oncologica, 2024-05, Vol.63 (1), p.343-350

2024

Volltextzugriff (PDF)

Epigenome-wide gene-age interaction analysis reveals reversed effects of PRODH DNA methylation on survival between young and elderly early-stage NSCLC patients

Aging (Albany, NY.), 2020-06, Vol.12 (11), p.10642-10662

2020

Volltextzugriff (PDF)

Dynamic changes in the T cell receptor repertoire during treatment with radiotherapy combined with an immune checkpoint inhibitor

Molecular oncology, 2021-11, Vol.15 (11), p.2958-2968

2021

Volltextzugriff (PDF)

Final efficacy and safety data, and exploratory molecular profiling from the phase III ALUR study of alectinib versus chemotherapy in crizotinib-pretreated ALK-positive non-small-cell lung cancer

ESMO open, 2022-02, Vol.7 (1), p.100333-100333, Article 100333

2022

Volltextzugriff (PDF)

Factors associated with delayed treatment initiation in an unselected cohort of patients with small-cell lung cancer

Cancer treatment and research communications, 2021, Vol.29, p.100477-100477, Article 100477

2021

Volltextzugriff (PDF)

Mutation testing for non-small-cell lung cancer

Tidsskrift for den Norske Lægeforening, 2012-04, Vol.132 (8), p.952-955

2012

Volltextzugriff (PDF)

Lung cancer

Tidsskrift for den Norske Lægeforening, 2001-02, Vol.121 (4), p.407

Alexandersen, O

2001

Volltextzugriff (PDF)

Is mediastinoscopy a necessary preoperative procedure in non-small cell lung cancer?

Tidsskrift for den Norske Lægeforening, 2002-09, Vol.122 (23), p.2268-2269

2002

Volltextzugriff (PDF)

Surgery for non-small cell lung cancer

Tidsskrift for den Norske Lægeforening, 2003-05, Vol.123 (11), p.1525-1526

2003

Volltextzugriff (PDF)

Serum RNAs can predict lung cancer up to 10 years prior to diagnosis

eLife, 2022-02, Vol.11

2022

Volltextzugriff (PDF)

SIPA1L3 methylation modifies the benefit of smoking cessation on lung adenocarcinoma survival: an epigenomic–smoking interaction analysis

Molecular oncology, 2019-05, Vol.13 (5), p.1235-1248

2019

Volltextzugriff (PDF)

Knockdown of SPRY4 and SPRY4-IT1 inhibits cell growth and phosphorylation of Akt in human testicular germ cell tumours

Scientific reports, 2018-02, Vol.8 (1), p.2462-8, Article 2462

2018

Volltextzugriff (PDF)

Durable and dynamic hTERT immune responses following vaccination with the long-peptide cancer vaccine UV1: long-term follow-up of three phase I clinical trials

Journal for immunotherapy of cancer, 2022-05, Vol.10 (5), p.e004345

2022

Volltextzugriff (PDF)

Tyrosine Kinase Inhibitors Target B Lymphocytes

Biomolecules (Basel, Switzerland), 2023-02, Vol.13 (3), p.438

2023

Volltextzugriff (PDF)

Recurrence and survival after surgical treatment of lung cancer

Tidsskrift for den Norske Lægeforening, 2010-01, Vol.130 (1), p.25-28

2010

Volltextzugriff (PDF)

PET-CT in the assessment of lung cancer at Rikshospitalet from 2007-2011

Tidsskrift for den Norske Lægeforening, 2014-05, Vol.134 (9), p.938-944

2014

Volltextzugriff (PDF)

Molecular biology in the diagnosis of lung cancer

Tidsskrift for den Norske Lægeforening, 2005-12, Vol.125 (23), p.3283-3285

Haugen, Aage

2005

Volltextzugriff (PDF)

Waiting time for surgery of lung cancer

Tidsskrift for den Norske Lægeforening, 2006-08, Vol.126 (15), p.1894-1897

2006

Volltextzugriff (PDF)

Is the treatment of lung cancer in Norway adequate?

Tidsskrift for den Norske Lægeforening, 2002-09, Vol.122 (23), p.2258-2262

2002

Volltextzugriff (PDF)

Mortality in operable lung cancer

Tidsskrift for den Norske Lægeforening, 1992-08, Vol.112 (18), p.2340

1992

Volltextzugriff (PDF)

1 – 25 von 26

Suche als RSS-Feed

Aktive Filter

SpracheNorwegisch

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(25)
Mit Volltextzugriff
(25)

Publikationsform

Artikel
(26)

Sprache

Englisch
(16)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Humans
(26)
Lung Neoplasms - Pathology
(21)
Male
(18)
Female
(17)
Aged
(15)
Middle Aged
(13)
Science & Technology
(13)
Carcinoma, Non-Small-Cell Lung - Pathology
(12)
Life Sciences & Biomedicine
(12)
Adult
(9)
Oncology
(9)
Lung Neoplasms - Diagnosis
(8)
Lung Neoplasms - Genetics
(8)
Lung Neoplasms - Surgery
(8)
Lung Cancer
(7)
Lung Neoplasms - Mortality
(7)
Prognosis
(7)
Survival Rate
(7)
Carcinoma, Non-Small-Cell Lung - Genetics
(6)
Aged, 80 And Over
(5)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Tidsskrift For Den Norske Lægeforening
(11)
Molecular Oncology
(4)
Lung Cancer
(2)
Acta Oncologica
(1)
Aging
(1)
Biomolecules
(1)
Cancer Treatment And Research Communications
(1)
Elife
(1)
Esmo Open
(1)
Frontiers In Immunology
(1)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Immune Cell Composition in Human Non-small Cell Lung Cancer

The immune microenvironment in non‐small cell lung cancer is predictive of prognosis after surgery

Osimertinib in T790M-positive and -negative patients with EGFR-mutated advanced non-small cell lung cancer (the TREM-study)

A multi‐omic study reveals BTG2 as a reliable prognostic marker for early‐stage non‐small cell lung cancer

Patient-reported health-related quality of life from a randomized phase II trial comparing standard-dose with high-dose twice daily thoracic radiotherapy in limited stage small-cell lung cancer

Evaluation of sex inequity in lung-cancer-specific survival

Epigenome-wide gene-age interaction analysis reveals reversed effects of PRODH DNA methylation on survival between young and elderly early-stage NSCLC patients

Dynamic changes in the T cell receptor repertoire during treatment with radiotherapy combined with an immune checkpoint inhibitor

Final efficacy and safety data, and exploratory molecular profiling from the phase III ALUR study of alectinib versus chemotherapy in crizotinib-pretreated ALK-positive non-small-cell lung cancer

Factors associated with delayed treatment initiation in an unselected cohort of patients with small-cell lung cancer

Mutation testing for non-small-cell lung cancer

Lung cancer

Is mediastinoscopy a necessary preoperative procedure in non-small cell lung cancer?

Surgery for non-small cell lung cancer

Serum RNAs can predict lung cancer up to 10 years prior to diagnosis

SIPA1L3 methylation modifies the benefit of smoking cessation on lung adenocarcinoma survival: an epigenomic–smoking interaction analysis

Knockdown of SPRY4 and SPRY4-IT1 inhibits cell growth and phosphorylation of Akt in human testicular germ cell tumours

Durable and dynamic hTERT immune responses following vaccination with the long-peptide cancer vaccine UV1: long-term follow-up of three phase I clinical trials

Tyrosine Kinase Inhibitors Target B Lymphocytes

Recurrence and survival after surgical treatment of lung cancer

PET-CT in the assessment of lung cancer at Rikshospitalet from 2007-2011

Molecular biology in the diagnosis of lung cancer

Waiting time for surgery of lung cancer

Is the treatment of lung cancer in Norway adequate?

Mortality in operable lung cancer

Aktive Filter

Suchergebnisse filtern